
Madison (WQOW) - The U.S. Food and Drug Administration says it has approved a new vaccine to prevent seasonal influenza.
However, Agriflu, made by Novartis Vaccines and Diagnostics, is not intended to protect against the H1N1 virus. The FDA says the vaccine was approved using an accelerated approval process. Novartis demonstrated that the vaccine induces levels of antibodies in the blood that are effective in preventing seasonal flu, but it still needs to conduct further studies.
The FDA says that Agriflu, for ages 18 and older, is administered as a single injection in the upper arm. Novartis produces another licensed vaccine for seasonal flu, Fluvirin, approved for ages four and older.
According to the FDA, no vaccine is 100-percent effective in preventing disease, but vaccination is the key to flu prevention.
Comments Terms of Use: We welcome your participation in our community. Please keep your comments civil and on point. You must be at least 13 years of age to post comments. By submitting a comment, you agree to these
Terms of Service
You must be logged in to leave a comment. Login or register See all comments |